Wanted to make sure you gals heard the news about the neratinib trials. 33% reduction in recurrence after Herceptin. Whoa this is big news! So you would do your full year of herceptin then another year of this new neratinib in the "extended adjuvant" setting. And it's completed its phase 3 trial?! I haven't been this excited about breast cancer news in a long time. It's usually: "we tested a new vaccine on a rat and it slowed cancer, now we have no funding to begin clinical testing. Try us again in 15 years." No this is something that could affect a lot of us. I've also read some encouraging things about this new drug (or is it a vaccine?) in the metastatic setting. This good to hear as my wife will be done with her herceptin/perjeta in December and I hear it may be available by Jan 2015. It's decent timing!
http://www.onclive.com/web-exclusive...t-Cancer-Study